SARS-CoV-2-IgM/IgG-Test-Kit(Immunochromatographic-Assay) |
|||
EGIVD008 | EnoGene | CE-recogniton-IVD | EUR 350 |
Description: CE recogniton IVD |
Human IgG antibody Laboratories manufactures the most common sars test reagents distributed by Genprice. The Most Common Sars Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Most products are available in stock. Specificity: Most Category: Common Group: Sars Test
COX (Coxsackievirus Antibody IgG) ELISA test |
||
Biobase | 96T/Box | Ask for price |
Description: ELISA based test for quantitative detection of COX (Coxsackievirus Antibody IgG) |
SARS-CoV-2 Rapid Antigen Test Nasal |
||
Roche Diagnostics | 25 Tests/Kit | EUR 112.8 |
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
SARS-CoV-2 Antigen Rapid Test Kit |
||
UnScience | 1T | EUR 9.6 |
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again. |
SARS-CoV-2 Antigen Rapid Test Kit |
||
UnScience | 25T/kit | EUR 42 |
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection. |
zika IgG/IgM Test Card |
||
Innovation Biotech | 4.0mm (strip in a card) 25cards/box | EUR 3.6 |
Chikungunya IgG/IgM Test Card |
||
Innovation Biotech | 4.0mm (strip in a card) 25cards/box | EUR 0.7 |
Dengue IgG/IgM Rapid Test |
||
Hangzhou AllTest Biotech | 1 kit | Ask for price |
Common 4 types of cancer tissue array |
|||
CM481 | TissueArray | each | EUR 222 |
Description: Common 4 types of cancer tissue array, 48 cases/54 cores, with stage and grade data |
APC anti-human CD132 (common γ chain) |
|||
E16FHA132-025 | EnoGene | 25 tests | EUR 520 |
Description: Available in various conjugation types. |
APC anti-human CD132 (common γ chain) |
|||
E16FHA132-100 | EnoGene | 100 tests | EUR 1213.33 |
Description: Available in various conjugation types. |
APC anti-mouse CD132 (common γ chain) |
|||
E16FMA132-025U | EnoGene | 25 μg | EUR 563.33 |
Description: Available in various conjugation types. |
APC anti-mouse CD132 (common γ chain) |
|||
E16FMA132-100U | EnoGene | 100 μg | EUR 1408.33 |
Description: Available in various conjugation types. |
Mouse antibody for Strep pneumoniae common |
|||
481 | Virostat | 100 ug | EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against Strep pneumoniae common for WB, ELISA. |
Mouse antibody for Strep pneumoniae common |
|||
491 | Virostat | 100 ug | EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against Strep pneumoniae common for WB, ELISA. |
Mouse antibody for Strep pneumoniae common |
|||
492 | Virostat | 100 ug | EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against Strep pneumoniae common for WB, ELISA. |
Mouse antibody for Strep pneumoniae common |
|||
461 | Virostat | 100 ug | EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against Strep pneumoniae common for WB, ELISA. |
Mouse antibody for Strep pneumoniae common |
|||
471 | Virostat | 100 ug | EUR 386.26 |
Description: This is purified Mouse monoclonal antibody against Strep pneumoniae common for WB, ELISA. |
Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test |
|||
BSV-COV-11711125 | BioServUK | 25 tests | Ask for price |
Description: Avacta AffiDX SARS-CoV-2 Antigen Lateral Flow Test |
Lysis Buffer for SARS-CoV-2 Antigen Test Development |
|||
LY-14 | ACROBIOSYSTEMS | 10ml | EUR 973.7 |
Description: N/A |
2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma) |
|||
GEN-402-25tests | All test | 25 tests | EUR 292.8 |
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
7 types of common malignant tumor tissues |
|||
CTRL143 | TissueArray | each | EUR 54 |
Description: 7 types of common malignant tumor tissues, including pathology grade, TNM and clinical stage, 7 cases/14 cores |
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
|||
IOV87952 | INVBIO | 20T/kit | EUR 46.8 |
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
Purified anti-human CD132 (common γ chain) |
|||
E16FHU132-100U | EnoGene | 100 μg | EUR 455 |
Description: Available in various conjugation types. |
Common diseases of the lung, 15 cases (2.5mm) |
|||
LUD151 | Pantomics | 1 | EUR 228 |
Description: Lung disease tissue array, 7 types, 15 cases of normal, inflammatory and tumor tissues of the lung. |